Ketamine Suppresses the Ventral Striatal Response to Reward Anticipation: A Cross-Species Translational Neuroimaging Study

Convergent evidence implicates regional neural responses to reward anticipation in the pathogenesis of several psychiatric disorders, such as schizophrenia, where blunted ventral striatal responses to positive reward are observed in patients and at-risk populations. In vivo oxygen amperometry measurements in the ventral striatum in awake, behaving rats reveal reward-related tissue oxygen changes that closely parallel blood oxygen level dependent (BOLD) signal changes observed in human functional magnetic resonance imaging (fMRI), suggesting that a cross-species approach targeting this mechanism might be feasible in psychopharmacology. The present study explored modulatory effects of acute, subanaesthetic doses of ketamine—a pharmacological model widely used in psychopharmacological research, both preclinically and clinically—on ventral striatum activity during performance of a reward anticipation task in both species, using fMRI in humans and in vivo oxygen amperometry in rats. In a region-of-interest analysis conducted following a cross-over placebo and ketamine study in human subjects, an attenuated ventral striatal response during reward anticipation was observed following ketamine relative to placebo during performance of a monetary incentive delay task. In rats, a comparable attenuation of ventral striatal signal was found after ketamine challenge, relative to vehicle, in response to a conditioned stimulus that predicted delivery of reward. This study provides the first data in both species demonstrating an attenuating effect of acute ketamine on reward-related ventral striatal (O2) and fMRI signals. These findings may help elucidate a deeper mechanistic understanding of the potential role of ketamine as a model for psychosis, show that cross-species pharmacological experiments targeting reward signaling are feasible, and suggest this phenotype as a promising translational biomarker for the development of novel compounds, assessment of disease status, and treatment efficacy.

[1]  Jeffrey C. Cooper,et al.  Functional magnetic resonance imaging of reward prediction , 2005, Current opinion in neurology.

[2]  Andre F. Marquand,et al.  Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers , 2013, NeuroImage.

[3]  A. Meyer-Lindenberg,et al.  Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients , 2012, Schizophrenia Research.

[4]  Peter Kirsch,et al.  Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system: an event-related fMRI study , 2003, NeuroImage.

[5]  Jennifer Francois,et al.  Changes in reward-related signals in the rat nucleus accumbens measured by in vivo oxygen amperometry are consistent with fMRI BOLD responses in man , 2012, NeuroImage.

[6]  Samuel M. McClure,et al.  Predictability Modulates Human Brain Response to Reward , 2001, The Journal of Neuroscience.

[7]  M. Roesch,et al.  Separate Populations of Neurons in Ventral Striatum Encode Value and Motivation , 2013, PloS one.

[8]  T. Ono,et al.  Effects of reward anticipation, reward presentation, and spatial parameters on the firing of single neurons recorded in the subiculum and nucleus accumbens of freely moving rats , 2000, Behavioural Brain Research.

[9]  O. Grimm,et al.  Reduced striatal activation during reward anticipation due to appetite-provoking cues in chronic schizophrenia: A fMRI study , 2012, Schizophrenia Research.

[10]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[11]  H. Flor,et al.  Altered neural reward and loss processing and prediction error signalling in depression. , 2015, Social cognitive and affective neuroscience.

[12]  Timo Kurki,et al.  Effects of Subanesthetic Doses of Ketamine on Regional Cerebral Blood Flow, Oxygen Consumption, and Blood Volume in Humans , 2003, Anesthesiology.

[13]  Arno Villringer,et al.  Dysfunction of ventral striatal reward prediction in schizophrenia , 2006, NeuroImage.

[14]  Christopher S. Monk,et al.  Choice selection and reward anticipation: an fMRI study , 2004, Neuropsychologia.

[15]  P. Boesiger,et al.  Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action , 2012, PloS one.

[16]  Seiya Miyamoto,et al.  Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine , 1999, Brain Research.

[17]  J. Roiser,et al.  Neural correlates of change in major depressive disorder anhedonia following open-label ketamine , 2015, Journal of psychopharmacology.

[18]  Allison C. Nugent,et al.  Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review , 2015, Therapeutic advances in chronic disease.

[19]  D. Luckenbaugh,et al.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. , 2010, Archives of general psychiatry.

[20]  J. O'Doherty,et al.  Reward representations and reward-related learning in the human brain: insights from neuroimaging , 2004, Current Opinion in Neurobiology.

[21]  R. Carelli.  The nucleus accumbens and reward: neurophysiological investigations in behaving animals. , 2002, Behavioral and cognitive neuroscience reviews.

[22]  S. Kapur,et al.  Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. , 2012, Archives of general psychiatry.

[23]  Martyn G Boutelle,et al.  Measurement of brain tissue oxygen at a carbon paste electrode can serve as an index of increases in regional cerebral blood flow , 1997, Journal of Neuroscience Methods.

[24]  Janice W. Smith,et al.  Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia , 2009, Psychopharmacology.

[25]  K. Laws,et al.  The use of ketamine as an antidepressant: a systematic review and meta‐analysis , 2015, Human psychopharmacology.

[26]  E. Pfenninger,et al.  [The clinical use of S-(+)-ketamine--a determination of its place]. , 1998, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[27]  Steven C. R. Williams,et al.  Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat , 2006, NeuroImage.

[28]  J. Huxter,et al.  Differential Contributions of Infralimbic Prefrontal Cortex and Nucleus Accumbens during Reward-Based Learning and Extinction , 2014, The Journal of Neuroscience.

[29]  Brian Knutson,et al.  Ventral Striatal Activation during Reward Processing in Subjects with Ultra-High Risk for Schizophrenia , 2012, Neuropsychobiology.

[30]  E. Pfenninger,et al.  Die klinische Anwendung von S-(+)-Ketamin - eine Standortbestimmung , 1998 .

[31]  John P. Lowry,et al.  Real-time electrochemical monitoring of brain tissue oxygen: A surrogate for functional magnetic resonance imaging in rodents , 2010, NeuroImage.

[32]  Brian Knutson,et al.  Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens , 2001, The Journal of Neuroscience.

[33]  K. Petrowski,et al.  [Mood in the German population: norms of the Multidimensional Mood Questionnaire MDBF]. , 2012, Psychotherapie, Psychosomatik, medizinische Psychologie.

[34]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[35]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[36]  J. Price,et al.  The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. , 2000, Cerebral cortex.

[37]  S. Krach,et al.  Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women. , 2009, Social cognitive and affective neuroscience.

[38]  Peter Kirsch,et al.  Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia. , 2014, JAMA psychiatry.

[39]  T. Robbins,et al.  Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat , 2013, European Neuropsychopharmacology.

[40]  Peter Kirsch,et al.  Test–retest reliability of evoked BOLD signals from a cognitive–emotive fMRI test battery , 2012, NeuroImage.

[41]  Peter Dayan,et al.  A Neural Substrate of Prediction and Reward , 1997, Science.